Interleukin-2 Treatment for Wiskott-Aldrich Syndrome

Clinical trial NCT00774358 · COMPLETED

Trial details

NCT number: NCT00774358
Sponsor: Soma Jyonouchi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Wiskott-Aldrich Syndrome (WAS)X-linked Thrombocytopenia

Start date: 2008-10-01
Primary completion: 2016-09-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.